Use of a new drug delivery formulation of the gonadotrophin-releasing hormone analogue Deslorelin for reversible long-term contraception in male dogs.
D000818:Animals; D003267:Contraception / Q000379:methods; D003272:Contraceptive Agents, Male / Q000008:administration & dosage*; D003692:Delayed-Action Preparations; D004285:Dogs; D004343:Drug Implants; D007986:Luteinizing Hormone / Q000097:blood; D008297:Male; D009929:Organ Size; D011467:Prostate / Q000033:anatomy & histology; D012661:Semen / Q000166:cytology; D013737:Testis / Q000033:anatomy & histology; D013739:Testosterone / Q000097:blood; D017329:Triptorelin Pamoate / Q000008:administration & dosage / Q000031:analogs & derivatives*
D003272:Contraceptive Agents, Male; D003692:Delayed-Action Preparations; D004343:Drug Implants; D017329:Triptorelin Pamoate; D013739:Testosterone; D007986:Luteinizing Hormone; C066438:deslorelin